INLUPREVE
Dead / Abandoned — Abandoned — express abandonment (as of 12 Apr 2025)
What this means for you
This application is over — abandoned 11 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98896134
- Mark type
- Stylized text
- Filed
- 11 Dec 2024
- Abandoned
- 11 Apr 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 12 Apr 2025 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 12 Apr 2025 — ABANDONMENT - EXPRESS MAILED
- 11 Apr 2025 — TEAS EXPRESS ABANDONMENT RECEIVED
- 11 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Dec 2024 — NEW APPLICATION ENTERED